| | | TAVR | SAVR | OR (95% CI) | value |
| | Primary endpoints | | | | | | Early mortality, n (%) | 29/565 (5.1) | 32/583 (5.5) | 0.89 (0.49, 1.62) | | | One-year mortality, n (%) | 50/432 (11.6) | 53/450 (11.8) | 1.01 (0.59, 1.72) | | | Overall mortality, n (%) | 129/565 (22.8) | 113/583 (19.4) | 1.17 (0.79, 1.73) | | | Stroke, n (%) | 16/417 (3.8) | 35/443 (7.9) | 0.52 (0.27, 0.98) | | | Acute kidney injury, n (%) | 55/565 (9.7) | 38/435 (8.7) | 1.00 (0.49, 2.07) | | | Major adverse events, n (%) | 39/450 (8.7) | 59/479 (12.3) | 0.60 (0.28, 1.32) | | | Secondary endpoints | | | | | | Major bleeding, n (%) | 47/565 (8.3) | 89/583 (15.3) | 0.43 (0.19, 0.79) | | | Permanent pacemaker, n (%) | 64/565 (11.3) | 23/583 (3.9) | 2.79 (1.24, 6.28) | | | Moderate paravalvular leakage, n (%) | 57/396 (14.4) | 0/384 (0) | 29.57 (7.09, 123.4) | | | Severe paravalvular leakage, n (%) | 43/396 (10.9) | 0/384 (0) | 23.44 (5.60, 98.17) | | | Procedural time (range), mean ± SD | (48 ± 11) to (225 ± 60) | (145 ± 33) to (384 ± 92) | −2.80 (−3.65, −1.95) | | | Hospital stay (range), mean ± SD | (5 ± 0) to (12 ± 6) | (8 ± 0) to (15 ± 14) | −0.38 (−0.58, −0.19) | |
|
|
